Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-195263 in Evaporative Dry Eye
NCT02965846Phase 3Terminated
- Sponsor
- Allergan
- Start
- Dec 2016
- Primary completion
- Jun 2017
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial in dry eye syndrome (DED) comparing AGN-195263 Arm with Vehicle Arm (2 arms). Primary endpoint: Overall Ocular Discomfort Score at 6 months. Started Dec 2016; status: terminated.
02
Drugs
AGN-195263
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02965846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965846.